Mark Hagler

Mark Hagler currently serves as Chief Commercial Officer at SUN PHARMA, overseeing a $1 billion business with full P&L responsibility and leading a team of over 600 in commercial operations and sales. Mark has extensive experience in the pharmaceutical industry, having held key positions at various companies including Board Member at SLAM BioTherapeutics and former Board Member at Ranbaxy Signature JV. Prior roles include Head of Oncology Marketing at Ipsen, Vice President of Business Development at Axess Oncology, and US Commercial Brand Leader at Sanofi. Educational credentials include an MBA in Finance from The Johns Hopkins University and a Bachelor of Science in Engineering from the United States Naval Academy.